Global X Japan Co. Ltd. Purchases 4,140 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Global X Japan Co. Ltd. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,289 shares of the medical equipment provider’s stock after buying an additional 4,140 shares during the period. Intuitive Surgical comprises 3.0% of Global X Japan Co. Ltd.’s portfolio, making the stock its 12th largest holding. Global X Japan Co. Ltd.’s holdings in Intuitive Surgical were worth $24,161,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Berbice Capital Management LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at about $26,000. Godsey & Gibb Inc. increased its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on ISRG shares. Raymond James lifted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Bernstein Bank boosted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. BTIG Research lifted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Finally, Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG opened at $588.50 on Friday. The firm has a market capitalization of $209.61 billion, a PE ratio of 91.81, a price-to-earnings-growth ratio of 5.51 and a beta of 1.39. The company has a 50-day simple moving average of $553.03 and a two-hundred day simple moving average of $512.59. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Insider Activity at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Jamie Samath sold 269 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. The trade was a 2.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,940 shares of company stock valued at $3,333,485 in the last three months. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.